Coyle Financial Counsel’s AbbVie ABBV Stock Holding History

Coyle Financial Counsel’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.96M	Buy	7,780 +105	+1%	+$22.6K	0.36%	28
2026 Q1	$1.67M	Sell	7,675 -339	-4%	-$75.2K	0.35%	31
2025 Q4	$1.83M	Buy	8,014 +752	+10%	+$171K	0.39%	31
2025 Q3	$1.68M	Buy	7,262 +194	+3%	+$39.5K	0.39%	32
2025 Q2	$1.31M	Buy	7,068 +11	+0.2%	+$2.04K	0.35%	36
2025 Q1	$1.48M	Buy	7,057 +179	+3%	+$34.8K	0.45%	36
2024 Q4	$1.22M	Sell	6,878 -175	-2%	-$32.2K	0.39%	43
2024 Q3	$1.21M	Buy	7,053 +91	+1%	+$17K	0.42%	41
2024 Q2	$1.27M	Hold	6,962	–	–	0.45%	38
2024 Q1	$1.27M	Hold	6,962	–	–	0.45%	38
2023 Q4	$1.08M	Buy	6,962 +20	+0.3%	+$2.92K	0.41%	40
2023 Q3	$1.03M	Sell	6,942 -77	-1%	-$11.3K	0.43%	40
2023 Q2	$946K	Buy	7,019 +2	+0%	+$293	0.43%	39
2023 Q1	$1.12M	Buy	7,017 +250	+4%	+$38.2K	0.51%	35
2022 Q4	$1.09M	Hold	6,767	–	–	0.53%	34
2022 Q3	$908K	Sell	6,767 -623	-8%	-$89.4K	0.6%	34
2022 Q2	$1.13M	Hold	7,390	–	–	0.62%	34
2022 Q1	$1.2M	Buy	7,390 +287	+4%	+$41.7K	0.64%	34
2021 Q4	$962K	Sell	7,103 -34	-0.5%	-$4.02K	0.57%	36
2021 Q3	$770K	Buy	7,137 +27	+0.4%	+$3.08K	0.45%	40
2021 Q2	$801K	Sell	7,110 -404	-5%	-$45.5K	0.48%	38
2021 Q1	$813K	Buy	7,514 +511	+7%	+$54.7K	0.56%	34
2020 Q4	$750K	Hold	7,003	–	–	0.55%	34
2020 Q3	$613K	Hold	7,003	–	–	0.51%	37
2020 Q2	$688K	Buy	7,003 +234	+3%	+$20.6K	0.64%	33
2020 Q1	$516K	Buy	6,769 +720	+12%	+$61.3K	0.64%	34
2019 Q4	$536K	Buy	+6,049	New	+$502K	0.5%	40
2018 Q3	–	Sell	-134	Closed	-$12K	–	33
2018 Q2	$12K	Buy	+134	New	+$13.1K	0.01%	99

Other funds holding ABBV

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Coyle Financial Counsel's ABBV Position: Q2 2026 in Review

Coyle Financial Counsel increased its AbbVie (ABBV) stake by 1.4% in Q2 2026, buying an estimated $22.6K and bringing the position to 7,780 shares worth $1.96M. The position accounts for 0.36% of the portfolio, ranked #28.

Coyle Financial Counsel first reported a position in ABBV in Q2 2018 and has held it in 28 quarters since. 4,224 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

Coyle Financial Counsel held 7,780 shares of AbbVie worth $1.96M as of Q2 2026.
Coyle Financial Counsel bought 105 AbbVie shares in Q2 2026, an estimated $22.6K.
AbbVie made up 0.36% of Coyle Financial Counsel's portfolio in Q2 2026, its #28 holding.
Coyle Financial Counsel first reported a position in AbbVie in Q2 2018 and has held it in 28 quarters since.
4,224 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Coyle Financial Counsel's 13F filing for Q2 2026, filed 7 Aug 2026.